In addition, triptolide indirectly affected the proliferation of MM cells by inhibiting IL-6, IL-1β, and stem cell factor (SCF) expression and vascular endothelial growth factor (VEGF) secretion and was suggested to possess a potential anti-MM effect (Wu et al., 2019). This evidence concerns the gene VEGFA and Miyoshi myopathy.